98%
921
2 minutes
20
Typhoid and emerging paratyphoid fever are a severe enteric disease worldwide with high morbidity and mortality. Licensed typhoid vaccines are in the market, but no paratyphoid vaccine is currently available. In the present study we developed a bivalent vaccine against Salmonella Typhi and Paratyphi A using a bacterial ghost platform. Bacterial ghost cells (BGs) are bacteria-derived cell membranes without cytoplasmic contents that retain their cellular morphology, including all cell surface features. Furthermore, BGs have inherent adjuvant properties that promote an enhanced humoral and cellular immune reaction to the target antigen. Sodium hydroxide was used to prepare ghost cells of Salmonella Typhi and Paratyphi A. The bacterial ghost cells were characterised using electron microscopy. Then BALB/c mice were immunized three times (0, 14 and 28 day) with the bivalent typhoidal bacterial ghost cells. Haematological study of adult mice throughout immunization period reflected that the immunogen was safe to administer and does not affect the animals' health. After complete immunization, we found significant serum antibody titter against whole cell lysate, outer membrane protein and lipopolysaccharide of both bacteria, and cell-mediated immunity was observed in an ex-vivo experiment. CD4+, CD8a+ and CD19+ splenic cell populations were increased in immunized animals. Bivalent Typhoidal ghost cell immunized mice showed better survival, less bacterial colonization in systemic organs, and less inflammation and/or destruction of tissue in histopathological analysis than non-immunized control mice.Serum antibodies of immunized animals can significantly inhibit bacterial motility and mucin penetration ability with better killing properties against Salmonella Typhi and Paratyphi A. Furthermore, significant passive protection was observed through the adoptive transfer of serum antibody and lymphocytes of immunized animals to naïve animals after bacterial infection. In summary, Bivalent Typhoidal Bacterial Ghost cells (BTBGs) enhances immunogenic properties and serves as a safe and effective prevention strategy against Salmonella Typhi and Paratyphi A.
Download full-text PDF |
Source |
---|---|
http://dx.doi.org/10.1016/j.vaccine.2023.08.049 | DOI Listing |
Cinnamaldehyde is a natural compound known for its antimicrobial and anticancer properties. Fourteen novel cinnamaldehyde-chalcone analogues (5a-5n) were synthesized and evaluated for anti-cancer, anti-bacterial, and anti-fungal activities. Among these, bromoethane chalcone 5n exhibited significant cytotoxicity against DU145 (IC50: 8.
View Article and Find Full Text PDFACS Appl Bio Mater
September 2025
Department of Bioengineering, University of Texas at Arlington, Arlington, Texas 76010, United States.
Probiotic bacteria have emerged as versatile and biocompatible platforms for drug delivery, offering a safe and efficient means of targeting diseased tissues. Advances in nanotechnology and genetic engineering have significantly expanded the potential of probiotic bacteria in precision medicine, enabling the delivery of therapeutics, proteins, antigens, and nanoparticles (NPs). This review explores diverse strategies for utilizing probiotics as drug carriers, including bacterial ghosts, outer membrane vesicles (OMVs), surface membrane proteins, and spores, focusing on applications in cancer therapy, vaccine development, and gastrointestinal disorders.
View Article and Find Full Text PDFBiomolecules
August 2025
Departamento de Bioquímica, Instituto de Química, Universidade de São Paulo, São Paulo 05508-220, Brazil.
Antimicrobial peptides (AMPs) are a primary defense against pathogens. Here, we examined the interaction of two BP100 analogs, RR-BP100 (where Arg substitutes Lys 2 and 5) and RR-BP100-A-NH-C (where an Ala and a C hydrocarbon chain are added to the RR-BP100 C-terminus), with membrane models. Large unilamellar vesicles (LUVs) and giant unilamellar vesicles (GUVs) were prepared with the major lipids in Gram-positive (GP) and Gram-negative (GN) bacteria, as well as red blood cells (RBCs).
View Article and Find Full Text PDFFish Shellfish Immunol
August 2025
Department of Aquatic Animal Medicine and Management, Faculty of Veterinary Medicine, Assiut University, 71526, Assiut, Egypt.
Aquaculture faces significant challenges from bacterial pathogens such as Pseudomonas putida, which causes severe infections in Nile tilapia (Oreochromis niloticus), leading to economic losses and public health concerns. To address this, a bacterial ghost vaccine of P. putida (PPGs) was developed using a sponge-like reduced protocol, ensuring structural integrity and complete inactivation while preserving immunogenic surface components.
View Article and Find Full Text PDFLangmuir
August 2025
INQUISUR - CONICET, Department of Chemistry, Universidad Nacional del Sur, Bahía Blanca B8000CPB, Argentina.
The increasing use of silver nanoparticles (AgNPs) in medical applications highlights the need for thorough studies of their health effects, particularly at the cellular level. Due to the complexity of replicating real cell membranes, Langmuir monolayers (LMs) are employed as simplified models of the initial biological barrier. These systems allow for controlled conditions to investigate molecular behavior at the membrane interface, offering insights into the fundamental mechanisms involved.
View Article and Find Full Text PDF